Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Feb 05, 2021

SELL
$5.65 - $7.66 $159,211 - $215,851
-28,179 Closed
0 $0
Q3 2020

Nov 06, 2020

BUY
$4.01 - $6.29 $112,997 - $177,245
28,179 New
28,179 $164,000

Others Institutions Holding ISEE

About IVERIC bio, Inc.


  • Ticker ISEE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 118,078,000
  • Description
  • IVERIC bio, Inc., a biopharmaceutical company, discovers and develops novel treatments for retinal diseases with a focus on age-related and orphan inherited retinal diseases (IRDs). The company develops Zimura, an inhibitor of complement factor C5 comprising GATHER1, which has completed Phase 2/3 clinical trial; and GATHER2 that is in Phase 3 cl...
More about ISEE
Track This Portfolio

Track Tiff Advisory Services Inc Portfolio

Follow Tiff Advisory Services Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tiff Advisory Services Inc, based on Form 13F filings with the SEC.

News

Stay updated on Tiff Advisory Services Inc with notifications on news.